A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...
"If it ain't broke, don't fix it," goes the old adage, which Rice University professor James Chappell completely ignored in a recent Nature Communications publication. In the study, Chappell describes ...
The protein UBR7 acts as a histone chaperone, regulating histone re-deposition at specific sites during DNA replication, according a recent study published in The EMBO Journal. This protein was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results